Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037778 · ClinicalTrials.gov registry record
Genetic Modifiers of Cystic Fibrosis: Sibling Study
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 3,459
- Enrollment target
NCT00037778: Completed study, sponsored by Johns Hopkins University.
NCT00037778 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 3,459 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00037778 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 3,459 participants
- Enrollment target
Study Summary
The purpose of this study is to identify modifier genes in cystic fibrosis (CF).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,459 participants |
| Start Date | 2001-09 |
| Est. Completion | 2013-02 |
What the finished NCT00037778 record still lists
NCT00037778 is an observational study that tracks outcomes without assigning an intervention. Its 3,459 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00037778 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00037778 about?
NCT00037778 is a clinical study titled "Genetic Modifiers of Cystic Fibrosis: Sibling Study". The purpose of this study is to identify modifier genes in cystic fibrosis (CF).
What is the current status of trial NCT00037778?
This trial is currently completed. The enrollment target is 3,459 participants. The study started on 2001-09. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT00037778?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia